{"id":"W87703995","doi":"10.2165/00044011-200828100-00003","title":"Evaluation of a New Formulation of Fenofibric Acid, ABT-335, Co-Administered with Statins","year":2008,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Atorvastatin; Combination therapy; Rosuvastatin; Fenofibrate; Rosuvastatin Calcium; Simvastatin; Statin; Pharmacotherapy; Internal medicine; Pharmacology; Clinical endpoint; Clinical trial; Fibrate; Randomized controlled trial; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532799,0.00046296,0.0009999007,0.0003833738,0.0003292713,0.0005517483,0.0005814398,0.0006768865,0.001637516],"category_scores_gemma":[0.0007168893,0.0002541954,0.0004845114,0.0002365213,0.0003874961,0.0004755679,0.0002242403,0.001218538,0.0003337659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003825174,"about_ca_system_score_gemma":0.0006475658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001204071,"about_ca_topic_score_gemma":0.001512089,"domain_scores_codex":[0.9995938,0.0001601431,0.00003784338,0.00006568699,0.0000825841,0.00005992447],"domain_scores_gemma":[0.9997438,0.00005740497,0.00004313948,0.00001648867,0.00003033257,0.0001088281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3753105,0.03324606,0.004066785,0.0008551371,0.0008248028,0.00122005,0.0003215397,0.0009700987,0.4698463,0.0004168955,0.0009166421,0.1120051],"study_design_scores_gemma":[0.06266229,0.6869828,0.02291951,0.0001030724,0.00219473,0.002135553,0.0004026988,0.004838062,0.2083237,0.0001112612,0.009230527,0.00009573514],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973292,0.00145038,0.0003422969,0.0001492307,0.00006751993,0.0001523926,0.00006883602,0.00002201055,0.0004181046],"genre_scores_gemma":[0.9973259,0.0008348197,0.0009769389,0.00008756042,0.00007895441,0.00007582299,0.0001507242,0.000006723739,0.0004624482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001637516,"threshold_uncertainty_score":0.005478024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2015735245686092,"score_gpt":0.4060830115815734,"score_spread":0.2045094870129643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}